W zmieniajcym si krajobrazie farmakoterapii metabolicznej, trwajce globalne badania stale pogbiaj nasz wiedz na temat terapii opartych na inkretynach
Because semaglutide can lower triglycerides (which is protective), it may actually reduce recurrence risk in some patients
The quality of this is top-notch and it really delivered the results I was looking for
One large retrospective cohort found that GLP-1 agonist use was associated with a lower risk of pancreatic cancer compared to treatment with other antihyperglycemic drugs, particularly insulin
GLP-1 receptor agonists like semaglutide reduce appetite and promote weight loss, but approximately 25-30% of weight loss can come from lean muscle tissue if proper countermeasures aren't taken
[Google Scholar] 93.Choi S., Lew K.L., Xiao H., Herman-Antosiewicz A., Xiao D., Brown C.K., Singh S.V